A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.
Eligibility
Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
Accepted
1. Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both).
2. Ability to provide written informed consent.
Exclusion Criteria:
1. Known gastric malignancy.
2. Prior gastric surgery (excluding H. pylori eradication).
3. Contraindications to endoscopy or biopsy.
4. Known hereditary gastric cancer syndromes.
Primary outcome measure(s)
Prevalence of histologically confirmed early gastric cancer — 2 years Prevalence (proportion) of histologically confirmed early gastric cancer (EGC) detected on biopsy or endoscopic resection specimen during the endoscopy.
Trial sites (1)
Facility
City
Region
Status
AIG Hospitals
Hyderabad
Telangana
Recruiting
More Asian Institute of Gastroenterology, India trials in India
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.